Funds and ETFs HK inno.N Corporation

Equities

A195940

KR7195940002

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
37,700 KRW -1.44% Intraday chart for HK inno.N Corporation -0.79% -15.19%

ETFs positioned on HK inno.N Corporation

Name Weight AuM 1st Jan change Investor Rating
0.00% 4 M€ -4.41% -
0.00% 34 M€ +3.53% -
HK Inno.N Corp is a Korea-based company mainly engaged in the manufacture and sale of prescription drugs. The Company operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The Company sells its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
37,700 KRW
Average target price
53,750 KRW
Spread / Average Target
+42.57%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A195940 Stock
  4. Funds and ETFs HK inno.N Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW